Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleMinireviews

Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target

Natalie E. Scholpa and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics December 2017, 363 (3) 303-313; DOI: https://doi.org/10.1124/jpet.117.244806
Natalie E. Scholpa
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona (N.E.S., R.G.S.); and Southern Arizona VA Health Care System, Tucson, Arizona (R.G.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rick G. Schnellmann
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona (N.E.S., R.G.S.); and Southern Arizona VA Health Care System, Tucson, Arizona (R.G.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 363 no. 3 303-313
DOI 
https://doi.org/10.1124/jpet.117.244806
PubMed 
28935700

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received August 28, 2017
  • Accepted September 20, 2017
  • Published online November 1, 2017.

Article Versions

  • Earlier version (September 21, 2017 - 08:51).
  • You are viewing the most recent version of this article.
Copyright & Usage 
U.S. Government work not protected by U.S. copyright

Author Information

  1. Natalie E. Scholpa and
  2. Rick G. Schnellmann
  1. Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona (N.E.S., R.G.S.); and Southern Arizona VA Health Care System, Tucson, Arizona (R.G.S.)
  1. Address correspondence to:
    Rick G. Schnellmann, Department of Pharmacology and Toxicology, University of Arizona, 1295 N. Martin, P.O. Box 210202, Tucson, AZ 85721. E-mail: schnell{at}pharmacy.arizona.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2017 to January 2021

AbstractFullPdf
Sep 2017157076
Oct 20171613129
Nov 201747711498
Dec 20171852929
Jan 2018981329
Feb 201849923
Mar 2018611260
Apr 2018671040
May 2018811822
Jun 201849517
Jul 201836930
Aug 2018401130
Sep 201845918
Oct 2018481133
Nov 201803745
Dec 201824045
Jan 201943843
Feb 201925536
Mar 201925951
Apr 201925546
May 201955049
Jun 201924228
Jul 201944328
Aug 201914727
Sep 201948029
Oct 201958339
Nov 201964552
Dec 201965021
Jan 20204359
Feb 202003213
Mar 202054518
Apr 2020114616
May 202053715
Jun 202022416
Jul 20202437
Aug 202042012
Sep 202034019
Oct 202034324
Nov 202065419
Dec 202084143
Jan 202143018

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 363 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 363, Issue 3
1 Dec 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleMinireviews

Mitochondrial Biogenesis for Spinal Cord Injury Treatment

Natalie E. Scholpa and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics December 1, 2017, 363 (3) 303-313; DOI: https://doi.org/10.1124/jpet.117.244806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleMinireviews

Mitochondrial Biogenesis for Spinal Cord Injury Treatment

Natalie E. Scholpa and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics December 1, 2017, 363 (3) 303-313; DOI: https://doi.org/10.1124/jpet.117.244806
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • SCI Pathology
    • Current Treatment of SCI: The National Acute Spinal Cord Injury Study and Methylprednisolone
    • Mitochondrial-Based Treatment
    • Mitochondrial Biogenesis
    • Conclusions
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Molecular Predictors of Response to Treatment in DME
  • Glycoconjugation in Psoriasis Treatment
  • Use of Tissue Biopsy in Human PK-ADME Studies
Show more Minireviews

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics